https://www.thebodypro.com/category/prep-hiv-pre-exposure-prophylasxis/tag/news-analysis

The Latest

intramuscular injection

HIV PrEP Is Finally About to Get Its Shot

PrEP for HIV is a pill. It has always been a pill. But it will not always be a pill, thanks to two major trials evaluating cabotegravir, an integrase inhibitor formulated for intramuscular injection, as PrEP.

By David Alain Wohl, M.D.
prescription bottle

PrEP and Prior Authorization: A Discriminatory Cheap Ploy

An important new analysis describes a key barrier to PrEP in the U.S., one that is almost sinister in its application predominantly in southern states.

By David Alain Wohl, M.D.
Undetectable = Untransmittable -- CATIE Signs On Img

Factors Associated With Hepatitis C Infection Among Men Who Take PrEP

IPERGAY scientists recommended that clinicians screen patients who request PrEP, as well as patients who are already using it, for a number of key HCV risk factors.

By Sean R. Hosein for Canadian AIDS Treatment Information Exchange
Senior woman receives prescription medication from doctor

Should All PrEP Users on Truvada Switch to Descovy? These Leading Docs Say, ‘Not So Fast.’

Many fear the push to put more people on the new brand-name drug before Truvada goes generic this year.

By Larry Buhl
Facebook logo reflected in an eye

Misleading Ads About PrEP Are Threatening Progress to End the HIV Epidemic. They Must Be Removed.

Pre-exposure prophylaxis (PrEP) is a vital part of ending HIV, but ads targeting people to join lawsuits are planting needless fears in patients, three leading HIV specialists write.

By Demetre C. Daskalakis, M.D., M.P.H., Oni Blackstock, M.D., M.H.S. and David Holland, M.D., M.H.S.
Customer giving medical prescription to pharmacist

What Needs to Happen Before California Pharmacies Can Sell PrEP and PEP Without an Initial Prescription

Pharmacists will increasingly play a role in pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) access in California.

By Larry Buhl
Hand holding syringe in backlight

Controversy Erupts Around Study on Contraception and HIV Risk

The ECHO trial faces backlash and criticism.

By Sony Salzman
Mexico City's Downtown At Twilight

IAS 2019: What to Expect in HIV Science

Six thousand HIV researchers and experts are expected to make their way to Mexico City for the 10th International AIDS Society Conference on HIV Science, which will feature more than 1,000 abstracts highlighting the latest findings in HIV treatment, prevention, and public health policy.

By Sony Salzman
Close up of doctor examining of test sample under the microscope

Researchers Discuss Ethics and Privacy Concerns About the Growing Field of HIV Adherence Monitoring

"A lot of patients want to know, 'Who else is going to see this data?'" said Peter Chai of Fenway Health in Boston.

By Kenyon Farrow
Fleur De Kine

New Campaign, Toolkit Gets Providers PrEP'd for Women

New York City aims to expand PrEP and PEP access by educating more clinicians that serve women.

By Kenyon Farrow